Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas

Journal of Urology

Volumn 162, Issue 3 I, 1999, Pages 905-909

  Kitagawa, Yasuhide ^a   Kunimi, Kazuto ^b   Uchibayashi, Tadao ^b   Sato, Hiroshi ^b   Namiki, Mikio ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Membrane type matrix metalloproteinase; Renal cell carcinoma; RT PCR

Indexed keywords

COLLAGENASE; GELATINASE A; MESSENGER RNA; PHOSPHORUS 32; STROMELYSIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0032835586     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199909010-00088     Document Type: Article

References (29)

1. Matrisian, L. M.: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6: 121, 1990.
2. Mignatti, P. and Rifkin, D. B.: Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73: 161, 1993.
3. Van Wart, H. E. and Birkendal-Hansen, H.: The cysteine switch: a principle of regulation of matrixmetalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA, 87: 5578, 1990.
4. Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A.: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol., 9: 541, 1993.
5. Nagase, H. and Okada, Y.: Proteinases and matrix degradation. In: Textbook of Rheumatology. Edited by W. N. Kelley, E. D. Harris, Jr., S. Ruddy, and W. B. Sledge. Philadelphia: W. B. Saunders Co., pp. 323-341, 1997.
6. Atkinson, S. J., Ward, R. V., Reynolds, J. J. and Murphy, G.: Cell-mediated degradation of type collagen and gelatin films is dependent on the activation of matrix metalloproteinase. Biochem. J., 194: 721, 1990.
7. Strongin, A. Y., Marmer, B. L., Grant, G. A. and Goldberg, G. I.: Plasma membrane-dependent activation of 72 kDa type collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268: 14033, 1993.
8. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M.: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond. ), 370: 61, 1994.
9. Will, H. and Hinzmann, B.: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem., 231: 602, 1995.
10. Takino, T., Sato, H., Sinagawa, A. and Seiki, M.: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem., 270: 23013, 1995.
11. Puente, X. S., Pendas, A. M., Liano, E., Velasco, G. and Lopez-Otin, C.: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res., 56: 944, 1996.
12. Nomura, H., Sato, H., Seiki, M., Mai, M. and Okada, Y.: Expression of membrane type matrix metalloproteinase in human gastric carcinomas. Cancer Res., 55: 3263, 1995.
13. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y. and Seiki, M.: Activation of the precursor of gelatinase A/72 kDa type collagenase/MMP-2 in lung carcinomas correlates with expression of membrane-type matrix metalloproteinase (MT-MMP) and lymph node metastasis. Int. J. Cancer, 64: 355, 1995.
14. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M. and Okada, Y.: Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res., 57: 2055, 1997.
15. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A. Nicolson, G. L. and Rao, J. S.: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56: 384, 1996.
16. Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P. and Basset, P.: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA, 92: 2730, 1995.
17. Yoshizaki, T., Sato, H., Maruyama, Y., Murono, S., Furukawa, M., Park, C. and Seiki, M.: Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer, 79: 139, 1997.
18. Kitagawa, Y., Kunimi, K., Ito, H., Sato, H., Uchibayashi, T., Okada, Y., Seiki, M. and Namiki, M.: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. J. Urol., 160: 1540, 1998.
19. Mostfi, F.: Histological typing of kidney tumors. In: International Histological Classification of Tumors, No. 25, Genova: WHO, 1981.
20. Beahrs, O. H.: American joint committee on cancer. In: Manual for Staging of Cancer, 4th ed. Philadelphia: J. B. Lippincott, 1992.
21. Ng, S., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T. and Kedes, L.: Evolution of the functional human β-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol., 5: 2720, 1985.
22. Tanaka, M., Sato, H., Takino, T., Iwata, K., Inoue, M. and Seiki, M.: Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product. FEBS Lett., 402: 219, 1997.
23. Matsumoto, S., Katoh, M., Saito, S., Watanabe, T. and Masuho, Y.: Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim. Biophys. Acta, 1354: 159, 1997.
24. Kovacs, G.: The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours. World J. Urol., 12: 64, 1994.
25. Wilhelm, M., Krause, U. and Kovacs, G.: Diagnosis and prognosis of renal-cell tumors: a molecular approach. World J. Urol., 13: 143, 1995.
26. Sene, A. P., Hunt, L., McMahon, R. F. T. and Carroll, R. N. P.: Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br. J. Urol., 70: 125, 1992.
27. Morita, R., Ishikawa, J., Tsutsumi, M., Hikiji, K., Tsukada, Y., Kamidono, S., Maeda, S. and Nakamura, Y.: Allelotype of renal cell carcinoma. Cancer Res., 51: 820, 1991.
28. Ogawa, O., Kakehi, Y., Ogawa, K., Koshiba, M., Sugiyama, T. and Yoshida, O.: Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res., 51: 949, 1991.
29. Ogawa, O., Habuchi, T., Kakehi, Y., Koshiba, M., Sugiyama, T. and Yoshida, O.: Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res., 52: 1881, 1992.